Heng Ren Rejects Sinovac Insider Buyout Offer

In a new letter to company management, Sinovac Biotech Ltd. SVA 0.09% shareholder Heng Ren Investments voices the firm’s displeasure over Sinovac insiders’ plan to take the company private.

On January 28, 2016, after eight years of development, China’s Food and Drug Administration approved Sinovac’s Hand Foot & Mouth (HFM) vaccine EV71. The very next day, company insiders announced a plan to take the company private at only a 6.6 premium to the previous day’s closing price.

Heng Ren points out that the buyout price the insiders are offering is 17.9 percent below the stock’s 2014 high and represents only about 57 percent of Sinovac’s true value.

“The Insiders’ attempt to begin the removal of financial partners only one business day after the go-ahead for the commercialization of the all-important EV71 vaccine, and avoid sharing the upside with loyal shareholders, is a sobering look into this leadership’s character and ethics,” Heng Ren writes.

Heng Ren makes the following four demands of Sinovac management:

  • 1. Raise the buyout offer of $6.18/ADS closer to Heng Ren’s estimated $10.84/ADS value estimates.
  • 2. Demonstrate loyalty to the shareholders that funded the costly development of EV71.
  • 3. Remove…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!